Jenifer Prather RN MPH, Clinical Trial Educator with Quintiles, will present an overview of the NMO301 Prevent clinical trial sponsored by Alexion Pharmaceuticals. The PREVENT study is designed to better understand Neuromyelitis Optica by evaluating the safety and efficacy of Eculizumab in relapsing NMO and NMO Spectrum Disorder (NMO-SD).
*** SRNA does not advocate for one study over another and as a patient advocacy group, our goal is to share information on all studies and educate and inform our community.
SRNA website has details on all the others studies currently available. Click here for more information.